Hualan Biological Engineering, Inc.

  • Market Cap: Large Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CNE000001JN8
CNY
12.78
-0.17 (-1.31%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Comparison

Company
Score
Quality
Valuation
Financial
Technical
Hualan Biological Engineering, Inc.

Why is Hualan Biological Engineering, Inc. ?

1
Poor long term growth as Net Sales has grown by an annual rate of -2.01% and Operating profit at -12.11% over the last 5 years
2
Flat results in Mar 26
  • NET PROFIT(9M) At CNY 649.3 MM has Grown at -31.17%
  • OPERATING CASH FLOW(Y) Lowest at CNY 1,127.25 MM
  • ROCE(HY) Lowest at 7.18%
3
Consistent Underperformance against the benchmark over the last 3 years
  • Along with generating -16.56% returns in the last 1 year, the stock has also underperformed China Shanghai Composite in each of the last 3 annual periods
stock-recommendationReal-Time Research Report

Verdict Report

How much should you sell?

  1. All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Hualan Biological Engineering, Inc. for you?

Low Risk, Low Return

Absolute
Risk Adjusted
Volatility
Hualan Biological Engineering, Inc.
-18.55%
-1.42
19.21%
China Shanghai Composite
21.43%
1.55
13.83%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor
Value
Sales Growth (5y)
-2.01%
EBIT Growth (5y)
-12.11%
EBIT to Interest (avg)
100.00
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.21
Sales to Capital Employed (avg)
0.38
Tax Ratio
13.41%
Dividend Payout Ratio
194.17%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
24.57%
ROE (avg)
14.71%
stock-recommendationValuation

Valuation Scorecard stock-summary

stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary

Factor
Value
P/E Ratio
27
Industry P/E
Price to Book Value
2.10
EV to EBIT
20.21
EV to EBITDA
16.80
EV to Capital Employed
2.58
EV to Sales
4.68
PEG Ratio
NA
Dividend Yield
4.48%
ROCE (Latest)
12.77%
ROE (Latest)
7.74%
stock-recommendationTechnicals

Technical key factors

Indicator
Weekly
Monthly
MACD
Bearish
Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Bearish
Dow Theory
Mildly Bearish
Mildly Bearish
OBV
Mildly Bearish
Mildly Bearish
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
stock-recommendationFinancial Trend

Financial Trend Scorecard stock-summary

stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

2What is working for the Company
INTEREST COVERAGE RATIO(Q)

The company hardly has any interest cost

-13What is not working for the Company
NET PROFIT(9M)

At CNY 649.3 MM has Grown at -31.17%

OPERATING CASH FLOW(Y)

Lowest at CNY 1,127.25 MM

ROCE(HY)

Lowest at 7.18%

CASH AND EQV(HY)

Lowest at CNY 7,884.85 MM

INVENTORY TURNOVER RATIO(HY)

Lowest at 0.85 times

NET SALES(Q)

Lowest at CNY 762.11 MM

Here's what is not working for Hualan Biological Engineering, Inc.

Net Sales
At CNY 762.11 MM has Fallen at -33.54%
over average net sales of the previous four periods of CNY 1,146.66 MM
MOJO Watch
Near term sales trend is extremely negative

Net Sales (CNY MM)

Net Profit
At CNY 649.3 MM has Grown at -31.17%
Year on Year (YoY)
MOJO Watch
Near term Net Profit trend is very negative

Net Profit (CNY MM)

Operating Cash Flow
Lowest at CNY 1,127.25 MM
in the last three years
MOJO Watch
The company's cash revenues from business operations are falling

Operating Cash Flows (CNY MM)

Net Sales
Lowest at CNY 762.11 MM
in the last five periods
MOJO Watch
Near term sales trend is negative

Net Sales (CNY MM)

Cash and Eqv
Lowest at CNY 7,884.85 MM
in the last six Semi-Annual periods
MOJO Watch
Short Term liquidity is deteriorating

Cash and Cash Equivalents

Inventory Turnover Ratio
Lowest at 0.85 times
in the last five Semi-Annual periods
MOJO Watch
Company's pace of selling inventory has slowed

Inventory Turnover Ratio